Cystic hygroma is a developmental abnormality of the lymphatic system in which enlarged, fluid-filled spaces form within soft tissues, most commonly in the neck. It is not cancer, but its location and extent can cause important complications. The term is used both for a finding detected during pregnancy and for a cystic mass identified after birth; these settings differ in their associated conditions and clinical significance.
Terminology and classification
Modern vascular-anomaly terminology generally describes cystic hygroma as a macrocystic lymphatic malformation. The older name cystic lymphangioma remains in use, although “lymphangioma” can misleadingly imply a true tumor rather than a developmental malformation.
Lymphatic malformations are classified by the size and arrangement of their cystic spaces:
- Macrocystic malformations contain relatively large cavities that can often be accessed individually during image-guided procedures.
- Microcystic malformations consist of much smaller spaces, often distributed throughout affected tissue.
- Mixed malformations contain both components.
The boundaries between these categories are not entirely uniform across publications. “Cystic hygroma” most often refers to a macrocystic lesion of the neck rather than to every type of lymphatic malformation.
In prenatal imaging, the term commonly describes an abnormal fluid collection behind and along the sides of the fetal neck, often divided by internal partitions called septa. This finding should not be treated as interchangeable with every instance of increased nuchal translucency.
Development and biological basis
The lymphatic system normally returns excess tissue fluid to the blood circulation. Abnormal development or drainage of embryonic lymphatic structures can produce dilated spaces containing lymph. These spaces are lined by endothelial cells and may extend between muscles, nerves, and blood vessels rather than remaining within a discrete capsule.
Many isolated lymphatic malformations contain a somatic activating mutation in the PIK3CA gene. Such mutations arise in a subset of cells during development and are usually not inherited. This mechanism does not account for every prenatal cystic hygroma, particularly those associated with chromosomal or syndromic conditions.
Although present developmentally, a malformation may not become noticeable until later childhood or, less commonly, adulthood. Enlargement can occur with growth, bleeding into the cysts, infection, or inflammation.
Presentation after birth
A typical presentation is a soft, sometimes compressible swelling in the neck, often toward its side or posterior portion. Other locations include the armpit, chest, abdomen, and groin. Deep lesions may be more extensive than their visible surface swelling suggests.
Clinical effects depend mainly on location and extent:
- Lesions involving the tongue, floor of the mouth, or deep neck can interfere with breathing, swallowing, or speech.
- Extension into the mediastinum can complicate assessment and treatment.
- Bleeding within a lesion may cause sudden enlargement, tenderness, and discoloration.
- Infection or inflammation may produce swelling, pain, and fever.
- Large or infiltrative lesions can alter appearance and impair local function.
These malformations do not metastasize. Their clinical importance results from their local effects and complications rather than malignant behavior.
Prenatal cystic hygroma
A fetal cystic hygroma can be detected by ultrasonography, sometimes during the first trimester. Its significance depends on gestational age, associated structural abnormalities, genetic findings, and whether the fluid collection persists or resolves.
Recognized associations include Turner syndrome, Down syndrome, other chromosomal abnormalities, and Noonan syndrome and related disorders. Congenital heart abnormalities may also be present. These are associations, not diagnoses established by the ultrasound appearance alone.
Some affected fetuses develop hydrops fetalis, an abnormal accumulation of fluid in multiple fetal compartments. Hydrops and major accompanying abnormalities are associated with poorer outcomes. Conversely, an isolated hygroma that resolves, with reassuring genetic and anatomical assessments, can have a substantially different outcome.
Prenatal evaluation may include detailed ultrasound, assessment of fetal heart anatomy, diagnostic genetic testing, and genetic counseling. Screening tests and diagnostic tests provide different levels of information: a screening result does not by itself establish or exclude all conditions associated with cystic hygroma.
Diagnosis and differential diagnosis
After birth, physical examination and imaging usually establish the nature and extent of the lesion. Ultrasound can show cystic spaces, internal septa, and evidence of bleeding. Doppler assessment generally demonstrates little or no flow within the cystic spaces, although vessels may be present in their walls or septa.
Magnetic resonance imaging is particularly useful for mapping deep extension and relationships to the airway, muscles, and other structures. Computed tomography is used in selected circumstances but involves ionizing radiation.
The differential diagnosis includes branchial cleft cysts, venous or combined vascular malformations, and other congenital or acquired neck masses. When tissue is examined, histopathology shows dilated lymphatic spaces lined by endothelial cells. Tissue sampling is not necessary for every lesion with characteristic clinical and imaging findings.
Management
Management is individualized according to symptoms, cyst structure, anatomical extent, and effects on breathing or feeding. Some small, uncomplicated lesions are observed. Symptomatic or extensive disease may involve specialists in pediatric surgery, otolaryngology, interventional radiology, and genetics.
Sclerotherapy involves image-guided injection of a substance that damages the cyst lining and promotes closure of the abnormal spaces. It is commonly used for macrocystic lesions, and more than one treatment may be required. Temporary swelling and inflammation are expected effects and can be important when a lesion lies near the airway.
Surgery can remove or reduce selected lesions. Complete removal may be difficult when abnormal spaces surround nerves, major vessels, or other essential structures. Potential complications include nerve injury, scarring, lymph leakage, and recurrence.
Systemic medicines, including sirolimus and selected pathway-targeted treatments, are used in some extensive or otherwise difficult-to-treat lymphatic malformations. Their use depends on the specific diagnosis and treatment setting and requires monitoring for adverse effects.
For large fetal neck masses, delivery planning may include specialized arrangements to establish and protect the newborn’s airway.
Prognosis
Prognosis varies substantially. A localized postnatal macrocystic lesion may respond well to treatment, whereas an extensive mixed or microcystic malformation may require repeated procedures and long-term follow-up. Residual abnormal lymphatic spaces can enlarge again after apparently successful treatment.
Prenatal prognosis cannot be inferred from the term “cystic hygroma” alone. Genetic findings, associated structural abnormalities, hydrops, and the course of the fluid collection are central determinants of outcome.